- Home
- DSGN vs CCBG Comparison
DSGN vs CCBG Comparison
Compare DSGN & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSGN | CCBG |
|---|---|---|
| Founded | 2017 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 853.8M | 828.1M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DSGN | CCBG |
|---|---|---|
| Price | $10.54 | $52.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | $21.71 | ★ $51.83 |
| AVG Volume (30 Days) | ★ 424.9K | 71.2K |
| Earning Date | 11-17-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | N/A | ★ 15.38 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.18 |
| Revenue Next Year | N/A | $3.29 |
| P/E Ratio | ★ N/A | $17.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.23 | $39.24 |
| 52 Week High | $17.25 | $53.60 |
Technical Indicators
Market Signals| Indicator | DSGN | CCBG |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 59.46 |
| Support Level | $9.83 | $50.98 |
| Resistance Level | $11.44 | $51.93 |
| Average True Range (ATR) | 0.58 | 1.08 |
| MACD | 0.09 | 0.26 |
| Stochastic Oscillator | 31.56 | 72.31 |
Price Performance
Historical ComparisonAbout DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.